share_log

Cowen & Co. Maintains Market Perform on FibroGen, Raises Price Target to $25

Benzinga ·  Feb 28, 2023 08:17

Cowen & Co. analyst Yaron Werber maintains FibroGen (NASDAQ:FGEN) with a Market Perform and raises the price target from $15 to $25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment